Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription

Articles published in
    July 2017
  1. CAHN DB, Handorf EA, Ghiraldi EM, Ristau BT, et al
    Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
    Cancer. 2017 Jul 25. doi: 10.1002/cncr.30900.
    >> Share

  2. VETTERLEIN MW, Wankowicz SAM, Seisen T, Lander R, et al
    Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
    Cancer. 2017 Jul 25. doi: 10.1002/cncr.30907.
    >> Share

  3. KOPP RP, Stratton KL, Glogowski E, Schrader KA, et al
    Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
    Cancer. 2017;123:2452-2458.
    >> Share

  4. PIATON E, Advenier AS, Carre C, Decaussin-Petrucci M, et al
    p16/Ki-67 dual labeling and urinary cytology results according to the New Paris System for Reporting Urinary Cytology: Impact of extended follow-up.
    Cancer. 2017;125:552-562.
    >> Share

    June 2017
  5. OJERHOLM E, Smith A, Hwang WT, Christodouleas JP, et al
    Reply to Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
    Cancer. 2017 Jun 30. doi: 10.1002/cncr.30871.
    >> Share

  6. DOLAN RD, McMillan DC
    Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
    Cancer. 2017 Jun 30. doi: 10.1002/cncr.30872.
    >> Share

  7. KORPICS MC, Block AM, Martin B, Hentz C, et al
    Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy.
    Cancer. 2017 Jun 5. doi: 10.1002/cncr.30719.
    >> Share

  8. RIMAR KJ, Tran PT, Matulewicz RS, Hussain M, et al
    The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies.
    Cancer. 2017;123:1912-1924.
    >> Share

  9. SCOTT SN, Ostrovnaya I, Lin CM, Bouvier N, et al
    Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guerin.
    Cancer. 2017;125:416-426.
    >> Share

    February 2017
  10. PACKIAM VT, Johnson SC, Steinberg GD
    Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guerin.
    Cancer. 2017;123:390-400.
    >> Share

  11. WANG H, Hoda RS, Faquin W, Rossi ED, et al
    FNA biopsy of secondary nonlymphomatous malignancies in salivary glands: A multi-institutional study of 184 cases.
    Cancer. 2017;125:91-103.
    >> Share

  12. MACLEOD LC, Pham KN, Agoff SN, Dahl KL, et al
    Cytologic persistence of malignant cells after transurethral resection of bladder tumors: Implications for concomitant manipulation of the urinary tract at the time of endoscopic resection.
    Cancer. 2017;125:114-119.
    >> Share

    October 2016
  13. OJERHOLM E, Smith A, Hwang WT, Baumann BC, et al
    Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.
    Cancer. 2016 Oct 27. doi: 10.1002/cncr.30422.
    >> Share

    August 2016
  14. PRINTZ C
    Arsenic in private well water may contribute to bladder cancer risk.
    Cancer. 2016;122:2291.
    >> Share

  15. DESAI NB, Scott SN, Zabor EC, Cha EK, et al
    Genomic characterization of response to chemoradiation in urothelial bladder cancer.
    Cancer. 2016 Aug 1. doi: 10.1002/cncr.30219.
    >> Share

    May 2016
  16. ROSE TL, Deal AM, Nielsen ME, Smith AB, et al
    Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer.
    Cancer. 2016 May 25. doi: 10.1002/cncr.30029.
    >> Share

    Mind the gap: What is driving the survival disparity between the sexes in bladder cancer?
    Cancer. 2016 May 25. doi: 10.1002/cncr.30027.
    >> Share

    March 2016
  18. ROSS JS, Wang K, Khaira D, Ali SM, et al
    Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations.
    Cancer. 2016;122:702-11.
    >> Share

  19. TULLY CM, Apolo AB, Zabor EC, Regazzi AM, et al
    The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.
    Cancer. 2016;122:712-21.
    >> Share

    January 2016
  20. CHOU R, Selph SS, Buckley DI, Gustafson KS, et al
    Treatment of muscle-invasive bladder cancer: A systematic review.
    Cancer. 2016 Jan 15. doi: 10.1002/cncr.29843.
    >> Share

    December 2015
  21. GREEN AK, Milowsky MI
    Genomic profiling of advanced bladder cancer to guide the use of targeted therapeutics.
    Cancer. 2015 Dec 9. doi: 10.1002/cncr.29825.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016